Clinical Trial Update: A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of pulmonary artery denervation for pulmonary hypertension associated with left heart failure; current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Mid-range Ejection Fraction
• Heart Failure with Preserved Ejection Fraction
• Heart Failure with Reduced Ejection Fraction
• Hypertension
• Pulmonary Hypertension

Snippet

Sponsor: Pulnovo Medical (Wuxi) Co., Ltd. | Conditions: Pulmonary Hypertension, Heart Failure With Reduced Ejection Fraction | Phase 3 | Status: RECRUITING